Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide

Annals of the New York Academy of Sciences

Volumn 786, Issue , 1996, Pages 120-134

  Hensley, K ^a   Butterfield, D A ^a   Hall, N ^a   Cole, P ^a   Subramaniam, R ^a   Mark, R ^b   Mattson, M P ^b   Markesbery, W R ^b   Harris, M E ^a   Aksenov, M ^a   Aksenova, M ^a   Wu, J F ^a   Carney, J M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMYLOID BETA PROTEIN; ANTIOXIDANT; GLUTAMIC ACID; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; AMINO ACID TRANSPORT; CONFERENCE PAPER; ENZYME INACTIVATION; NEUROPATHOLOGY; NEUROTOXICITY; OXIDATIVE STRESS; SENILE PLAQUE;

EID: 0029762276     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb39057.x     Document Type: Conference Paper

References (49)

1. GUTTERIDGE, J. M. C. 1993. Free Radical Res. Commun. 19: 141-148.
2. HENSLEY, K., N. HALL, R. SUBRAMANIAM, P. COLE, M. HARRIS, M. AKSENOV, M. AKSENOVA, S. P. GABBITA, J. F. WU, J. M. CARNEY, M. LOVELL, W. R. MARKESBERY & D. A. BUTTERFIELD. 1995. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65: 2146-2156.
3. SMITH, C. D., J. M. CARNEY, T. TATSUMO, E. R. STADTMAN, R. A. FLOYD & W. R. MARKESBERY. 1992. Protein oxidation in aging brain. Ann. N.Y. Acad. Sci. 663: 100-119.
4. OLIVER, C. N., B. W. AHN, E. J. MOERMAN, S. BOLDSTEIN & E. R. STADTMAN. 1987. Age-related changes in oxidized proteins. J. Biol. Chem. 262: 5488-5491.
5. MARKESBERY, W. R., M. A. LOVELL & W. D. EHMANN. 1994. Increased lipid peroxidation and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurobiol. Aging 15(Suppl): S139-S140.
6. BALAZS, L. & M. LEON. 1994. Evidence for an oxidative challenge in the Alzheimer's brain. Neurochem. Res. 19: 1131-1137.
7. BLASS, J. P. & G. E. GIBSON. 1991. Oxidative abnormalities in Alzheimer's disease. Rev. Neurol. 147: 513-525.
8. VOLICER, L. & P. B. CRINO. 1990. Involvement of free radicals in dementia of the Alzheimer type: a hypothesis. Neurobiol. Aging 11: 567-571.
9. CARNEY, J. M., P. E. STARDE-REED, C. N. OLIVER, R. W. LANDUM, M. S. CHENG, J. F. WU & R. A. FLOYD. 1991. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-α-phenyl nitrone. Proc. Natl. Acad. Sci. USA 88: 3633-3636.
10. STOLL, S., U. HAFNER, O. POHL & W. E. MULLER. 1994. Age-related memory decline and longevity under treatment with selegiline. Life Sci. 55: 2155-2163.
11. MARKESBERY, W. R., M. A. LOVELL & W. D. EHMANN. 1994. Brain trace metals in Alzheimer disease. In Alzheimer Disease. R. D. Terry, R. Katzman & K. L. Bick, Eds. 353-367. Raven Press. New York.
12. GERLACH, M., D. BEN-SHACHAR, P. RIEDERER & M. B. H. YOUDIM. 1994. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63: 793-807.
13. PARKER, W. D., JR., J. PARKS, C. M. FILLEY & B. K. KLEINSCHMIDT-DEMASTERS. 1994. Electron transport chain defects in Alzheimer's disease brain. Neurology 44: 1090-1096.
14. NUTISYA, E. M., A. C. BOWLING & M. F. BEAL. 1994. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63: 2179-2184.
15. SMITH, M. A., S. TANEDA, P. L. RICHEY, S. MIKYATA, S. YAN, D. STERN, L. SAYER, V. M. MONNIER & G. PERRY. 1994. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA 91: 5710-5714.
16. COLTON, C. A., J. SNELL, O. CHERNYSHEV & D. L. GILBERT. 1994. Induction of superoxide anion and nitric oxide production in cultured microglia. Ann. N.Y. Acad. Sci. 728: 54-63.
17. BEHL, C., J. DAVIS, G. M. COLE & D. SCHUBERT. 1992. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186: 944-950.
18. DYRKS, T., E. DYRKS, T. HARTMAN, C. MASTERS & K. BEYREUTHER. 1992. Amyloidogenicity of βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267: 18210-18217.
19. HENSLEY, K., J. M. CARNEY, M. P. MATTSON, M. AKSENOVA, M. HARRIS, J. F. WU, R. A. FLOYD & D. A. BUTTERFIELD. 1994. A model for β-amyloid aggregation and neurotoxicity based of free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91: 3270-3274.
20. HENSLEY, K., M. AKSENOVA, J. M. CARNEY & D. A. BUTTERFIELD. 1995. Amyloid β-peptide spin trapping I: enzyme toxicity is related to free radical spin trap reactivity. NeuroReport 6: 489-493.
21. HENSLEY, K., M. AKSENOVA, J. M. CARNEY & D. A. BUTTERFIELD. 1995. Amyloid β-peptide spin trapping II: evidence for decomposition of the PBN spin adduct. NeuroReport 6: 493-496.
22. BUTTERFIELD, D. A., K. HENSLEY, M. HARRIS, M. P. MATTSON & J. M. CARNEY. 1994. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200: 710-715.
23. SNYDER, S. W., U. S. LADROR, W. S. WADE, G. T. WANG, L. W. BARRETT, E. D. MATAYOSHI, J. H. HUFFAKER, G. A. KRAFFT & T. F. HOLZMAN. 1995. Amyloid-β aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67: 1216-1228.
24. HARRIS, M. E., K. HENSLEY, D. A. BUTTERFIELD, R. E. LEEDLE & J. M. CARNEY. 1995. Direct evidence of oxidative injury by the Alzheimer's amyloid β peptide in cultured hippocampal neurons. Exp. Neurol. 131: 193-202.
25. HARRIS, M. E., J. M. CARNEY, P. COLE, K. HENSLEY, B. J. HOWARD, L. MARTIN, P. BUMMER, Y. WANG, N. PEDIGO & D. A. BUTTERFIELD. 1995. β-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: relevance to Alzheimer's disease. NeuroReport 1995. 6: 1875-1879.
26. 2+ homeostasis and cell death. J. Neurosci. 15: 6239-6249.
27. GOODMAN, Y. & M. P. MATTSON. 1994. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128: 1-12.
28. GOODMAN, Y., M. R. STEINER, S. M. STEINER & M. P. MATTSON. 1994. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attentuates free radical and calcium accumulation. Br. Res. 654: 171-176.
29. GOODMAN, Y. & M. P. MATTSON. 1994. Staurosporine and K-252 compounds protect hippocampal neurons against amyloid β-peptide toxicity and oxidative injury. Br. Res. 650: 170-174.
30. SCHUBERT, D., C. BEHL, R. LESLEY, A. BRACK, R. GARGUSCH, Y. SAGARA & H. KIMURA. 1995. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA 92: 1989-1993.
31. BEHL, C., J. B. DAVIS, R. LESLEY & D. SCHUBERT. 1994. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77: 817-827.
32. WHITTEMORE, E. R., D. T. LOO & C. W. COTMAN. 1994. Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. NeuroReport 5: 1485-1488.
33. TOMIYAMA, T., S. ASANO, Y. SUWA, T. MORIA, K. KATAOKA, H. MORI & N. ENDO. 1994. Rifampicin prevents the aggregation and neurotoxicity of amyloid β protein in vitro. Biochem. Biophys. Res. Commun. 204: 76-83.
34. KUMAR, U., D. M. DUNLOP & J. S. RICHARDSON. 1994. The acute neurotoxic effect of β-amyloid on mature cultures of rat hippocampal neurons is attenuated by the antioxidant U-78517F. Int. J. Neurosci. 79: 185-190.
35. SELKOE, D. J. 1994. Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53: 438-447.
36. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16: 409-414.
37. KANG, J., H. G. LEMAIRE, A. UNTERBECK, J. M. SALBAUM, C. L. MASTERS, K. H. GRZESCHIK, G. MULTHAUP, K. BEYREUTHER & B. MULLER-HILL. 1987. The precursor of Alzheimer's disease Amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736.
38. MULLAN, M., & F. CRAWFORD. 1993. Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16: 398-403.
39. GAMES, D., D. ADAMS, R. ALESSANDRINI, R. BARBOUR, P. BERTHELETTE, C. BLACKWELL, T. CARR, J. CLEMENS, T. DONALDSON, F. GILLESPIE, T. GUIDO, S. HAGOPLAN, K. JOHNSON-WOOD, K. KHAN, M. LEE, P. LEIBOWITZ, I. LIEBERBURG, S. LITTLE, E. MASLIAH, L. MCCONLOGUE, M. MONTOYA-ZAVALA, L. MUCKE, L. PAGANINI, E. PENNIMAN, M. POWER, D. SCHENK, P. SEUBERT, B. SNYDER, F. SORIANO, H. TAN, J. VITALE, S. WADSWORTH, B. WOLOZIN & J. ZHAO. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373: 523-527.
40. GOWING, E., A. E. ROHER, A. S. WOODS, R. J. COTTER, M. CHANEY, S. P. LITTLE & M. J. BALL. 1994. Chemical characterization of Aβ(17-42) peptide, a component of diffuse amyloid deposits of Alzheimer disease. J. Biol. Chem. 269: 10987-10990.
41. MAY, P. C., B. D. GITTER, D. C. WATERS, L. K. SIMMONS, G. W. BECKER, J. S. SMALL & P. M. ROBISON. 1992. β-amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol. Aging 13: 605-607.
42. PIKE, C. J., D. BURDICK, A. J. WALENCEWICZ, C. G. GLABE & C. W. COTMAN. 1993. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13: 1676-1687.
43. SIMMONS, L. K., P. C. MAY, K. J. TOMASELLI, R. E. RYDEL, K. S. FUSON, E. F. BRIGHAM, S. WRIGHT, I. LIEBERBURG, G. W. BECKER, D. N. BREMS & W. Y. LI. 1994. Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45: 373-379.
44. LORENZO, A. & B. A. YANKNER. 1994. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91: 12243-12247.
45. LACZKO, I., S. HOLLY, Z. KONYA, K. SOOS, J. L. KAJTAR, M. HOLLOSI & B. PENKE. 1994. Conformational mapping of amyloid peptides from the putative neurotoxic 25-35 region. Biochem. Biophys. Res. Commun. 205: 120-126.
46. DADO, G. P. & S. H. GELLMAN. 1994. Redox control of secondary structure in a designed peptide. J. Am. Chem. Soc. 115: 12606-12609.
47. STRITTMATTER, W. J., K. H. WEISGRABER, D. Y. HUANG, L. M. DONG, G. S. SALVESEN, M. PERICAK-VANCE, D. SCHMECHEL, A. M. SAUNDERS, D. GOLDGABER & A. D. ROSES. 1993. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 8098-8102.
48. VOLTERRA, A., D. TROTTI, C. TROMBA, S. FLORIDI & G. RACAGNI. 1994. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14: 2924-2932.
49. HARRIS, M. E. 1995. Dissertation, University of Kentucky, Lexington KY.